Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001015920 | SCV001176814 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001493248 | SCV001697871 | likely benign | Tuberous sclerosis 2 | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001493248 | SCV002039212 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004004554 | SCV004829533 | likely benign | Tuberous sclerosis syndrome | 2023-05-16 | criteria provided, single submitter | clinical testing |